Comprehensive overview of RNA sequencing and how to achieve research success.
Genetic diversity of SARS-CoV-2 from evolutionary analysis. Sequencing solutions and research strategies about the molecular epidemiology for clinical research, vaccine development and drug R&D.
Advanced and intuitive multi-omics data visualisation system for efficient analysis and discovery: "Dr. Tom"
Introduction of single cell sequencing, available technologies and their respective advantages. Combining 10X Genomics technology and DNBSEQ™ Sequencing Technology for highly cost-efficient single cell sequencing, with a real world case study of data example.
Different quantitative proteomics approaches, with common questions and challenges in proteomics experiment design.
Introduction of MGI global Service Centres. With rapid international expansion of the service and support teams, MGI is committed to providing the best product experience for customers everywhere.
MGI’s disruptive DNA Nanoball Sequencing (DNBSEQ) platforms generate high quality data for a variety of applications. Hear from Canada’s genomics leaders at BC Cancer's Michael Smith Genome Sciences Centre, University of British Columbia, and McGill Genome Centre on their experiences with MGIDNBSEQ platforms.
DNBSEQ-T7 has achieved major breakthroughs: the first 4-chip sequencing platform, completing PE150 at full load within 24 hours, generating 6Tb of data per day, and completing up to 60 whole human genomes per day. MGI presents the cancer genetic testing experience based on DNBSEQ-T7.
Recent COVID-19 publications based on applications of MGI high-throughput sequencing platforms and discuss novel topics e.g. evolution of SARS-CoV-2 separately from SARS, similar infection mode of COVID-19 to SARS, potential immune mechanism.
MGI's DNBSEQ-G50 sequencer now has a major upgrade, with improvements to flexibility, turnaround time and performance. Check out these new improvements.